Research on the Economics of Cancer-Related Health Care: An Overview of the Review Literature

Davidoff, Amy J.; Akif, Kaitlin; Halpern, Michael T.

doi:10.1093/jncimonographs/lgac011

Cited by 10 publications

(5 citation statements)

References 170 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…On the basis of changes in the annual number of published studies in cancer health economics research over time, research in this field has increased substantially during the past years. 10 However, a key challenge to further development of this area is fragmentation among organizations active in this domain. That is, multiple organizations collect data, conduct research, fund research, and/or disseminate findings from cancer health economics research.…”

Section: Fragmentation Of Cancer Health Economics Researchmentioning

confidence: 99%

“…Cancer health economics research has the potential to provide information and intervention strategies that will improve health care and patient-centered outcomes across the cancer control continuum, including services for cancer prevention, screening, treatment, and survivorship. On the basis of changes in the annual number of published studies in cancer health economics research over time, research in this field has increased substantially during the past years 10 . However, a key challenge to further development of this area is fragmentation among organizations active in this domain.…”

Section: Fragmentation Of Cancer Health Economics Researchmentioning

confidence: 99%

See 1 more Smart Citation

Enhancing Cancer Economic Data Resources

Halpern,

Ekwueme,

Yabroff

2023

Medical Care

View full text Add to dashboard Cite

Background: Cancer diagnosis and treatment can substantially affect health and financial outcomes for patients and families. Research in health care delivery across the cancer control continuum includes diverse activities led by multiple government and private sector organizations. Assessing the economic drivers and influencing factors associated with costs across this continuum is challenging as organizations leading research efforts often do not have forums to share data, develop linkages, and explore collaborative opportunities. Objective: To describe the objectives, activities, and goals of the Interagency Consortium to Promote Health Economics Research on Cancer (HEROiC) to strengthen data resources and capacity for collaborative patient-focused cancer health economics research. Main Argument: HEROiC’s goals include assessing the economic burden of cancer; examining the effects of policies, health care setting/system factors, and health service delivery approaches across the cancer control continuum; and enhancing collaborations among researchers and organizations. Conclusions: Data resources to study economic outcomes associated with cancer control are highly fragmented; HEROIC provides a forum to collaboratively develop, enhance, and utilize data resources and infrastructure for patient-centered cancer health economics research. This includes sharing data resources, developing linkages, identifying new data collection venues, and creating and supporting the dissemination of evidence-based information to diverse stakeholders. These efforts provide critical information to address the economic burden of cancer. Relevance to the Special Issue: Cancer diagnosis and treatment affect patient health and financial outcomes. This commentary describes how HEROiC will enhance research data infrastructure and collaborations to support patient-centered research with the goal of reducing the economic burden of cancer.

show abstract

Section: Fragmentation Of Cancer Health Economics Researchmentioning

confidence: 99%

Section: Fragmentation Of Cancer Health Economics Researchmentioning

confidence: 99%

Enhancing Cancer Economic Data Resources

Halpern,

Ekwueme,

Yabroff

2023

Medical Care

View full text Add to dashboard Cite

show abstract

“…Ці концепції враховано при розробці Програми медичних гарантій (ПМГ) і включення відповідних пакетів послуг, направлених на лікування онкологічних та онкогематологічних захворювань [1,8]. Проте імплементовані в Національній службі здоров'я України (НСЗУ) підходи до внесення взаємодій чи пролікованих випадків до пакетів напрямку "Онкологія", а також система їхнього фінансування потребують удосконалення [1,2,10,11].…”

Section: соціальна медицина організація охорони здоров'я вступunclassified

Comparative analysis of the medical guarantees program packages in the field of “Oncology”

Husak,

Zub,

Kotuza

2023

Rep. of Vinnytsia Nation. Med. Univ.

View full text Add to dashboard Cite

Annotation. The approaches implemented in the National Health Service of Ukraine (NHSU) for entering interactions or treated cases into packages in the field of “Oncology”, as well as the system of their financing, need constant improvement. The aim of the study is to assess the main inconsistencies and inaccuracies in the existing grouping rules regarding treated cases/interactions in packages in the field of “Oncology” and to formulate proposals for improving the Medical Guarantees Program in the field of “Oncology” based on the findings. A descriptive-analytical study was conducted for 8 months of the year 2022 comparing clinical approaches and compliance with the rate for medical services provided to patients with oncological and oncohematological diseases within the oncology packages of the Medical Guarantees Program with a comparison to Australian coding standards. As a result of the analysis, certain problems were revealed in the existing grouping rules regarding treated cases/interactions in the packages in the field of “Oncology”: unclear criteria for the inclusion of a case in the package, particularly the inclusion of diagnoses that are not related to malignant neoplasms; duplication of diagnoses in packages, which contributes to double/triple funding of the case; lack of medical and automatic monitoring for the correct coding of the main diagnosis and interventions; lack of ongoing analysis of services provided in outpatient settings from the point of view of their compliance with the rate, as well as failure to apply timely preventive measures. The proposed ways of improving the Medical Guarantees Program in the field of “Oncology” will allow to improve the equipment of diagnostic and treatment units for providing medical service to cancer patients due to the use of released/saved funds, which will lead to an increase in the survival rate of patients, timely diagnosis of cancer in the early stages and prevention of new cases of oncological diseases.

show abstract

“…3 The experience of financial toxicity in patients with cancer is now well described, owing to an increasingly robust body of literature characterizing its risk factors, manifestations, and consequences. Despite the recent steady increase in publications on the financial impact of cancer on patients, 4 there is limited research on interventions to mitigate financial toxicity, although the need for such work has been described in previous commentaries and research. [5][6][7] Although financial toxicity is acutely experienced at the patient level, interventions must consider the interconnected systems within which patients receive care.…”

Section: Introductionmentioning

confidence: 99%

Financial Toxicity Order Set: Implementing a Simple Intervention to Better Connect Patients With Resources

Thom

Sokolowski

Abu‐Rustum

et al. 2023

JCO Oncology Practice

View full text Add to dashboard Cite

PURPOSE: Financial toxicity of cancer treatment is well described in the literature, including characterizations of its risk factors, manifestations, and consequences. There is, however, limited research on interventions, particularly those at the hospital level, to address the issue. METHODS: From March 1, 2019, to February 28, 2022, a multidisciplinary team conducted a three-cycle Plan-Do-Study-Act (PDSA) process to develop, test, and implement an electronic medical record (EMR) order set to directly refer patients to a hospital-based financial assistance program. The cycles included an assessment of the efficacy of our current practice in connecting patients experiencing financial hardship with assistance, the development and piloting of the EMR referral order, and the broad implementation of the order set across our institution. RESULTS: In PDSA cycle 1, we found that approximately 25% of patients at our institution experienced some form of financial hardship, but most patients were not connected to available resources because of our referral mechanism. In PDSA cycle 2, the pilot referral order set was deemed feasible and received positive feedback. Over the 12-month study period (March 1, 2021-February 28, 2022) of PDSA cycle 3, 718 orders were placed for 670 unique patients across interdisciplinary providers from 55 treatment areas. These referrals resulted in at least $850,000 in US dollars (USD) in financial aid in 38 patients (mean = $22,368 USD). CONCLUSION: The findings from our three-cycle PDSA quality improvement project demonstrate the feasibility and efficacy of interdisciplinary efforts to develop a hospital-level financial toxicity intervention. A simple referral mechanism can empower providers to connect patients in need with available resources.

show abstract

Research on the Economics of Cancer-Related Health Care: An Overview of the Review Literature

Cited by 10 publications

References 170 publications

Enhancing Cancer Economic Data Resources

Enhancing Cancer Economic Data Resources

Comparative analysis of the medical guarantees program packages in the field of “Oncology”

Financial Toxicity Order Set: Implementing a Simple Intervention to Better Connect Patients With Resources

Contact Info

Product

Resources

About